An update in the prevention of psychotic spectrum disorders

Referencias bibliográficas

• Addington, J., Epstein, I., Liu, L., French, P., Boydell, K. M., y Zipursky, R. B. (2011). A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research, 125, 54–61.
• Addington, J., Stowkowy, J., y Weiser, M. (2015). Screening tools for clinical high risk for psychosis. Early Intervention in Psychiatry, 9, 345-356.
• Alameda, L., Golay, P., Baumann, P., Morandi, S., Ferrari, C., Conus, P., y Bonsack, C. (2016). Assertive outreach for “difficult to engage” patients: A useful tool for a subgroup of patients in specialized early psychosis intervention programs. Psychiatry Research, 239, 212–219.
• Amminger, G. P., Schafer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., … Berger, G. E. (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry, 67, 146–154.
• Bernardini, F., Attademo, L., Cleary, S. D., Luther, C., Shim, R. S., Quartesan, R., y Compton, M. T. (2017). Risk prediction models in psychiatry: Toward a new frontier for the prevention of mental illnesses. Journal of Clinical Psychiatry, 78, 572–583.
• Bobes, J., y Saiz, J. (2013). Impacto social de la esquizofrenia. Madrid: Janssen Pharmaceutica N.V.
• Borsboom, D. (2017). A network theory of mental disorders. World Psychiatry, 16, 5–13.
• Carpenter, W. (2018). Clinical high risk controversies and challenge for the experts. Schizophrenia Bulletin, 44, 223-225. doi: 10.1093/schbul/sbx182.
• Carrión, R., Correll, C., Auther, A., y Cornblatt, B. (2017). A severity-based clinical staging model for the psychosis prodrome: longitudinal findings from the new york recognition and prevention program. Schizophrenia Bulletin, 43, 64– 74.
• Cornblatt, B. A., y Carrión, R. E. (2016). Deconstructing the psychosis risk syndrome moving the field of prevention forward. JAMA Psychiatry, 73, 105-106. https://doi.org/10.1001/jamapsychiatry.2015.2454
• Csillag, C., Nordentoft, M., Mizuno, M., McDaid, D., Arango,
• C., Smith, J., … Jones, P. (2017). Early intervention in psychosis: From clinical intervention to health system implementation. Early Intervetion in Psychiatry, doi: 10.1111/eip.12514.
• Cuesta, M. J., y Peralta, V. (2016). Going beyond classic descriptions to future phenomenology of schizophrenia. JAMA Psychiatry, 73(10), 1010.
• Davis, J., Eyre, H., Jacka, F. N., Dodd, S., Dean, O., McEwen, S., … Berk, M. (2016). A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neuroscience and Biobehavioral Reviews, 65, 185-194.
• Debbané, M., Eliez, S., Badoud, D., Conus, P., Flückiger, R., y Schultze-Lutter, F. (2015). Developing psychosis and its risk states through the lens of schizotypy. Schizophrenia Bulletin, 41, S396-407.
• Dickson, H., Laurens, K. R., Cullen, A. E., y Hodgins, S. (2012). Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. Psychological Medicine, 42, 743–755.
• Dietsche, B., Kircher, T., y Falkenberg, I. (2017). Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies. Australian y New Zealand Journal of Psychiatry, 51, 500–508.
• Duffy, A., Malhi, G. S., y Grof, P. (2017). Do the trajectories of bipolar disorder and schizophrenia follow a universal staging model? Canadian Journal of Psychiatry, 62, 115-122. https://doi.org/10.1177/0706743716649189
• Fonseca-Pedrero, E. (2017). Análisis de redes: ¿una nueva forma de comprender la psicopatología? Revista de Psiquiatria y Salud Mental, 10, 206-215.
• Fonseca-Pedrero, E. (2018). Análisis de redes en Psicología. Papeles del Psicólogo, 39, 1-12.
• Fonseca-Pedrero, E. (2018). Evaluación de los trastornos del espectro psicótico. Madrid: Pirámide.
• Fonseca-Pedrero, E., y Debbané, M. (2018). Evaluación del riesgo de psicosis. En E. Fonseca-Pedrero (coord.) Evaluación de los trastornos del espectro psicótico (pp. 381-429). Madrid: Pirámide.
• Fonseca-Pedrero, E., Gooding, D., Debbané, M., y Muñiz, J. (2016). Psychopathology: Psychosis assessment and highrisk paradigms. En D. Bartram (Ed.), The ITC International Handbook of Testing and Assessment. Oxford, UK: Oxford University Press.
• Fonseca-Pedrero, E., Paino, M., y Fraguas, D. (2013). DSM-5: ¿Síndrome de psicosis atenuada? Papeles del Psicólogo, 34, 190–207.
• Fonseca Pedrero, E., y Debbané, M. (2017). Schizotypal traits and psychotic-like experiences during adolescence: An update. Psicothema, 29, 5–17.
• Fraser, R., Berger, G., y McGorry, P. (2006). Emerging psychosis in young people Part 2 key issues for acute management. Australian Family Physician, 35, 323-327. Fusar-Poli, P., Bonoldi, I., Yung, A. R., Borgwardt, S., Kempton, M. J., Valmaggia, L., … McGuire, P. (2012). Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry, 69, 220– 229.
• Fusar-Poli, P., Byrne, M., Badger, S., Valmaggia, L. R., y McGuire, P. K. (2013). Outreach and support in South London (OASIS), 2001-2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. European Psychiatry, 28, 315–326.
• Fusar-Poli, P., Carpenter, W. T., Woods, S. W., y McGlashan, T. H. (2014). Attenuated psychosis syndrome: ready for DSM-5.1? Annual Review of Clinical Psychology, 10, 155– 192.
• Fusar-Poli, P., Deste, G., Smieskova, R., Barlati, S., Yung, A. R., Howes, O., … Borgwardt, S. (2012). Cognitive functioning in prodromal psychosis: a meta-analysis. Archives of General Psychiatry, 69, 562–571.
• Fusar-Poli, P., McGorry, P., y Kane, J. (2017). Improving outcomes of first-episode psychosis: an overview. World Psychiatry, 16, 251–265.
• Fusar-Poli, P., Radua, J., McGuire, P., y Borgwardt, S. (2012). Neuroanatomical maps of psychosis onset: voxel-wise metaanalysis of antipsychotic-naive VBM studies. Schizophrenia Bulletin, 38, 1297–1307.
• Fusar-Poli, P., Rocchetti, M., Sardella, A., Avila, A., Brandizzi, M., Caverzasi, E., … McGuire, P. (2015). Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. British Journal of Psychiatry, 207, 198–206.
• Fusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., Bonoldi, I., Reilly, T., y McGuire, P. (2017). Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiatry, 74, 493–500.
• Fusar-Poli, P., Rutigliano, G., Stahl, D., Schmidt, A., RamellaCravaro, V., Hitesh, S., y McGuire, P. (2016). Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk. JAMA Psychiatry, 73(12), 1260.
• Fusar-Poli, P., Tantardini, M., De Simone, S., Ramella-Cravaro, V., Oliver, D., Kingdon, J., … McGuire, P. (2017). Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. European Psychiatry, 40, 65-75.
• Fusar-Poli, P., y Yung, A. R. (2012). Should attenuated psychosis syndrome be included in DSM-5? The Lancet, 379(9816), 591-592.
• Guloksuz, S., y van Os, J. (2018). The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Psychological Medicine, 48, 229-244.
• Häfner, H., y An Der Heiden, W. (1999). The course of schizophrenia in the light of modern follow-up studies: The ABC and WHO studies. European Archives of Psychiatry and Clinical Neuroscience, 249(Suppl. 4), IV14-IV26.
• Huber, G. (1983). Das Konzept substratnaher Basissymptome und seine Bedeutung für Theorie und Therapie schizophrener Erkrankungen. Nervenarzt, 54, 23–32.
• Humiston, S. G., Szilagyi, P. G., Iwane, M. K., Schaffer, S. J., Santoli, J., Shone, L., … Schwartz, B. (2004). The feasibility of universal influenza vaccination for infants and toddlers. Archives of Pediatrics & Adolescent Medicine, 158(9), 867– 874.
• Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., … Wang, P. (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. The American Journal of Psychiatry, 167(7), 748–751.
• Insel, T. R. (2017). Digital phenotyping: Technology for a new science of behavior. JAMA, 318, 1215-1216. https://doi.org/10.1001/jama.2017.11295
• Jeste, D. V., Palmer, B. W., y Saks, E. R. (2017). Why we need positive psychiatry for schizophrenia and other psychotic disorders. Schizophrenia Bulletin, 43(2), 227–229.
• Juuhl-Langseth, M., Holmén, A., Thormodsen, R., Øie, M., y Rund, B. R. (2014). Relative stability of neurocognitive deficits in early onset schizophrenia spectrum patients. Schizophrenia Research, 156(2–3), 241–247.
• Kaymaz, N., Drukker, M., Lieb, R., Wittchen, H. U., Werbeloff, N., Weiser, M., … van Os, J. (2012). Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychological Medicine, 20, 1–15.
• Kendler, K. S. (2014). The structure of psychiatric science. American Journal of Psychiatry,171, 931-938.
• Keshavan, M. S., DeLisi, L. E., y Seidman, L. J. (2011). Early and broadly defined psychosis risk mental states. Schizophrenia Research, 126, 1–10.
• Keshavan, M. S., Nasrallah, H. A., y Tandon, R. (2011). Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse. Schizophrenia Research, 127, 3-13.
• Keshavan, M. S., Tandon, R., Boutros, N. N., y Nasrallah, H. A. (2008). Schizophrenia, “just the facts”: What we know in 2008. Part 3: Neurobiology. Schizophrenia Research, 106, 89–107.
• Klosterkötter, J. (2014). The usefulness for indicated prevention of severe mental disorders should play a central part in the further development of CBT. World Psychiatry, 13, 259260.
• Kraepelin, E. (1919). Dementia praecox and paraphrenia. Huntington, N.Y.: Krieger (Trad.1971).
• Laine, A., Anttila, M., y Valimaki, M. (2016). Modification of an Internet-based patient education program for adults with schizophrenia spectrum disorder to suit adolescents with psychosis. Informatics for Health y Social Care, 41(3), 230– 246.
• Larsen, T. K., Melle, I., Auestad, B., Haahr, U., Joa, I., Johannessen, J. O., … McGlashan, T. (2011). Early detection of psychosis: positive effects on 5-year outcome. Psychological Medicine, 41, 1461–1469.
• Lemos Giráldez, S., Fonseca-Pedrero, E., Paino, M., y Vallina, O. (2015). Esquizofrenia y otros trastornos psicóticos. Madrid: Síntesis.
• Linscott, R. J., y van Os, J. (2013). An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychological Medicine, 43, 1133–1149.
• Lyne, J., O’Donoghue, B., Roche, E., Renwick, L., Cannon, M., y Clarke, M. (2017). Negative symptoms of psychosis: A life course approach and implications for prevention and treatment. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12501
• Maj, M. (2011). Understanding the pathophysiology of schizophrenia: are we on the right track? Schizophrenia Research, 127, 20–21.
• Marshall, M., y Rathbone, J. (2011). Early intervention for psychosis. In Cochrane Database of Systematic Reviews, Jun 15;(6):CD004718. doi: 10.1002/14651858.CD004718.pub3.
• McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., … Breier, A. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163(5), 790–799.
• McGorry, P., Johanessen, J. O., Lewis, S., Birchwood, M., Malla, A., Nordentoft, M., … Yung, A. (2010). Early intervention in psychosis: Keeping faith with evidence-based health care. Psychological Medicine, 40, 399-404.
• McGorry, P., y Van Os, J. (2013). Redeeming diagnosis in psychiatry: Timing versus specif i ci ty. The Lancet, 381(9863), 343–345.
• Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., … Weinberger, D. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485–515.
• Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Ventura, J., McFarlane, W., … Woods, S. W. (2003). Prodromal Assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability. Schizophrenia Bulletin, 29(4), 703–715.
• Miret, S., Fatjó-Vilas, M., Peralta, V., y Fañanás, L. (2016). Síntomas básicos en la esquizofrenia, su estudio clínico y relevancia en investigación. Revista de Psiquiatría y Salud Mental, 9(2), 111–122.
• Mongan, D., Shannon, C., Hanna, D., Boyd, A., y Mulholland, C. (2017). The association between specific types of childhood adversity and attenuated psychotic symptoms in a community sample. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12478
• Morrison, A. P., French, P., Stewart, S. L. K., Birchwood, M., Fowler, D., Gumley, A. I., … Dunn, G. (2012). Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ, 344, e2233.
• Morrison, A. P., Turkington, D., Pyle, M., Spencer, H., Brabban, A., Dunn, G., … Hutton, P. (2014). Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet, 383(9926), 1395–403.
• Mosholder, A. D., Gelperin, K., Hammad, T. a, Phelan, K., y Johann-Liang, R. (2009). Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics, 123(2), 611– 616.
• Muñiz, J., Hernández, A., y Ponsoda, V. (2015). Nuevas directrices sobre el uso de los tests: investigación, control de calidad y seguridad. Papeles del Psicólogo, 36, 161–173.
• Myin-Germeys, I., Oorschot, M., Collip, D., Lataster, J., Delespaul, P., y van Os, J. (2009). Experience sampling research in psychopathology: opening the black box of daily life. Psychological Medicine, 39(9), 1533.
• Nelson, B., McGorry, P. D., Wichers, M., Wigman, J. T. W., y Hartmann, J. A. (2017). Moving from static to dynamic models of the onset of mental disorder. JAMA Psychiatry, 74, 528 -534.
• Nelson, B., Parnas, J., y Sass, L. A. (2014). Disturbance of minimal self (ipseity) in schizophrenia: clarification and current status. Schizophrenia Bulletin, 40(3), 479–482.
• Niendam, T. A., Tully, L. M., Iosif, A. M., Kumar, D., Nye, K. E., Denton, J. C., … Pierce, K. M. (2018). Enhancing early psychosis treatment using smartphone technology: A longitudinal feasibility and validity study. Journal of Psychiatric Research, 96, 239–246.
• Obiols, J. E., y Barrantes-Vidal, N. (2014). Signos de riesgo y detección precoz de psicosis. Madrid: Síntesis.
• Parnas, J. (2015). Differential diagnosis and current polythetic classification. World Psychiatry, 14, 284–287.
• Pérez-Álvarez, M. (2012). Esquizofrenia y cultura moderna: Razones de la locura. Psicothema, 24, 1-9.
• Riley, M., Patterson, V., Lane, J. C., Won, K. M., y Ranalli, L. (2018). The Adolescent champion model: Primary care becomes adolescent-centered via targeted quality improvement. Journal of Pediatrics, 193, 229-236. doi: 10.1016/j.jpeds.2017.09.084
• Ruhrmann, S., Bechdolf, A., Kühn, K. U., Wagner, M., Schultze-Lutter, F., Janssen, B., … Klosterkötter, J. (2007). Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. British Journal of Psychiatry, 191(Suppl. 51), s88-95. doi: 10.1192/bjp.191.51.s88.
• Schmidt, A., Cappucciati, M., Radua, J., Rutigliano, G., Rocchetti, M., Dell’Osso, L., … Fusar-Poli, P. (2016). Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and metaanalytical sequential testing simulation. Schizophrenia Bulletin, 43, 375-388.
• Schultze-Lutter, F., Klosterkötter, J., y Ruhrmann, S. (2014). Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophrenia Research, 154(1–3), 100–106.
• Schultze-Lutter, F., Michel, C., Schmidt, S. J., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., … Klosterkötter, J. (2015). EPA guidance on the early intervention in clinical high risk states of psychoses. European Psychiatry, 30(3), 388–404.
• Segarra, R. (2013). Abordaje integral de las fases iniciales de las psicosis. Una visión crítica. Madrid: Editorial Médica Panamericana.
• Stafford, M. R., Jackson, H., Mayo-Wilson, E., Morrison, A. P., y Kendall, T. (2013). Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ, 346, f185.
• Tandon, R., Keshavan, M. S., y Nasrallah, H. A. (2008). Schizophrenia, “Just the Facts”: What we know in 2008. Part 1: Overview. Schizophrenia Research, 100, 4–19.
• Tandon, R., Nasrallah, H. A., y Keshavan, M. S. (2009). Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophrenia Research, 110, 1–23.
• Tsuang, M. T., Van Os, J., Tandon, R., Barch, D. M., Bustillo, J., Gaebel, W., … Carpenter, W. (2013). Attenuated psychosis syndrome in DSM-5. Schizophrenia Research, 150, 31–35.
• Valmaggia, L. R., Byrne, M., Day, F., Broome, M. R., Johns, L., Howes, O., … McGuire, P. K. (2015). Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase. British Journal of Psychiatry, 207(2), 130–134.
• van der Gaag, M., Nieman, D. H., Rietdijk, J., Dragt, S., Ising, H. K., Klaassen, R. M., … Linszen, D. H. (2012). Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophrenia Bulletin, 38, 1180–1188.
• van der Gaag, M., Smit, F., Bechdolf, A., French, P., Linszen, D. H., Yung, A. R., … Cuijpers, P. (2013). Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term followups. Schizophrenia Research, 149(1–3), 56–62.
• van Os, J., Delespaul, P., Wigman, J., Myin-Germeys, I., y Wichers, M. (2013). Beyond DSM and ICD: introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry, 12, 113–117.
• van Os, J., y Guloksuz, S. (2017). A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry, 16(2), 200–206.
• van Os, J., y Kapur, S. (2009). Schizophrenia. Lancet, 374, 635–645.
• van Os, J., Kenis, G., y Rutten, B. P. (2010). The environment and schizophrenia. Nature, 468, 203–312.
• van Os, J., y Linscott, R. J. (2012). Introduction: The extended psychosis phenotype Relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophrenia Bulletin, 38(2), 227–230.
• van Os, J., y Reininghaus, U. (2016). Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry, 15(2), 118–124.
• van Os, J., Reininghaus, U., y Meyer-Lindenberg, A. (2017). The Search for Environmental Mechanisms Underlying the Expression of Psychosis: Introduction. Schizophrenia Bulletin, 43, 283–286.
• Wyatt, R. J., y Henter, I. (2001). Rationale for the study of early intervention. Schizophrenia Research, 51(1), 69–76.
• Yung, A. R., y McGorry, P. D. (2007). Prediction of psychosis: setting the stage. British Journal of Psychiatry, 191, s1-8.
• Yung, A. R., Phillips, L. J., Nelson, B., Francey, S. M., PanYuen, H., Simmons, M. B., … McGorry, P. D. (2011). Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-Month analysis. Journal of Clinical Psychiatry, 72(4), 430–440.
• Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L. J., Kelly, D., Dell’Olio, M., … Buckby, J. (2005). Mapping the onset of psychosis-the Comprehensive Assessment of At Risk Mental States (CAARMS). Australian and New Zealand Journal of Psychiatry, 39, 964–971.
• Zarogianni, E., Storkey, A. J., Johnstone, E. C., Owens, D. G. C., y Lawrie, S. M. (2017). Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features. Schizophrenia Research, 181, 6–12.